biohacking techniques

Cedars-Sinai Event Explores Ethics of Longevity Science | Newswise — Photo by mori dad on Pexels

longevity science

Build a Bottom‑Up Budget: Cedars‑Sinai’s Ethics Panel Breaks Down Longevity Science Costs and Gene Therapy Pricing

Only 53% of FDA-approved gene therapies are priced below the average cost of anti-cancer treatments, showing the market often overcharges for longevity interventions. I unpack how Cedars-Sinai’s ethics panel separates hype from real value, revealing hidden costs and equity challenges. Medical Disclaimer: This article is for informational purposes only